Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity

Exploring the characteristics of the HIV-1 envelope glycoprotein (env) gene in a natural HIV-1 infected individual, with broadly neutralizing activity, may provide insight into the generation of such broadly neutralizing antibodies and initiate the design of an appropriate immunogen. Recently, a chr...

Full description

Bibliographic Details
Main Authors: Dai Zhang, Sen Zou, Yuanyuan Hu, Jiali Hou, Xintao Hu, Li Ren, Liying Ma, Xiang He, Yiming Shao, Kunxue Hong
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.01096/full
_version_ 1818517199768256512
author Dai Zhang
Dai Zhang
Sen Zou
Yuanyuan Hu
Jiali Hou
Xintao Hu
Li Ren
Liying Ma
Xiang He
Yiming Shao
Kunxue Hong
author_facet Dai Zhang
Dai Zhang
Sen Zou
Yuanyuan Hu
Jiali Hou
Xintao Hu
Li Ren
Liying Ma
Xiang He
Yiming Shao
Kunxue Hong
author_sort Dai Zhang
collection DOAJ
description Exploring the characteristics of the HIV-1 envelope glycoprotein (env) gene in a natural HIV-1 infected individual, with broadly neutralizing activity, may provide insight into the generation of such broadly neutralizing antibodies and initiate the design of an appropriate immunogen. Recently, a chronically HIV-1 infected patient with broadly neutralization activity was identified and a VRC01-class neutralizing antibody DRVIA7 (A7) was isolated from the patient. In the present study, 155 full length HIV-1 env gene fragments (including 68 functionally Env clones) were amplified longitudinally from the plasma of six time points spanning over 5 years in this donor. Viral features were analyzed by comparing Env clones of different time points, as well as 165 Chinese HIV-1 subtype B env sequences from HIV Sequence Database (Chinese B_database). Shorter V1 length, less potential glycan and a lower ratio of NXT: NXS in gp160 were observed in the first five time points compared to that from the last time points, as well that from the Chinese B_database. A sequence analysis and a neutralization assay of Env-pseudoviruses showed that the increasing diversity of env sequences in the patient was consistent with the appearance and maturation of A7 lineage antibodies. The potent neutralization activity and viruses that escaped from the neutralization of the concurrent autologous plasma, are consistent with higher residue variations at the antibody recognition sites. Almost all viruses from the plasmas were neutralization-resistant to VRC01 and A7 lineage antibodies. For a chronically HIV-1 infected individual over 10 years, we found that greater viral diversity, short V1 sequences and less potential N-linked glycosylation (PNGS) in V1, might be associated with the development of broadly neutralizing antibody responses.
first_indexed 2024-12-11T00:52:58Z
format Article
id doaj.art-85313d8705fa4e6aacf6c4def3272b32
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-11T00:52:58Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-85313d8705fa4e6aacf6c4def3272b322022-12-22T01:26:35ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2019-05-011010.3389/fmicb.2019.01096439719Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing ActivityDai Zhang0Dai Zhang1Sen Zou2Yuanyuan Hu3Jiali Hou4Xintao Hu5Li Ren6Liying Ma7Xiang He8Yiming Shao9Kunxue Hong10State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaThe First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, ChinaExploring the characteristics of the HIV-1 envelope glycoprotein (env) gene in a natural HIV-1 infected individual, with broadly neutralizing activity, may provide insight into the generation of such broadly neutralizing antibodies and initiate the design of an appropriate immunogen. Recently, a chronically HIV-1 infected patient with broadly neutralization activity was identified and a VRC01-class neutralizing antibody DRVIA7 (A7) was isolated from the patient. In the present study, 155 full length HIV-1 env gene fragments (including 68 functionally Env clones) were amplified longitudinally from the plasma of six time points spanning over 5 years in this donor. Viral features were analyzed by comparing Env clones of different time points, as well as 165 Chinese HIV-1 subtype B env sequences from HIV Sequence Database (Chinese B_database). Shorter V1 length, less potential glycan and a lower ratio of NXT: NXS in gp160 were observed in the first five time points compared to that from the last time points, as well that from the Chinese B_database. A sequence analysis and a neutralization assay of Env-pseudoviruses showed that the increasing diversity of env sequences in the patient was consistent with the appearance and maturation of A7 lineage antibodies. The potent neutralization activity and viruses that escaped from the neutralization of the concurrent autologous plasma, are consistent with higher residue variations at the antibody recognition sites. Almost all viruses from the plasmas were neutralization-resistant to VRC01 and A7 lineage antibodies. For a chronically HIV-1 infected individual over 10 years, we found that greater viral diversity, short V1 sequences and less potential N-linked glycosylation (PNGS) in V1, might be associated with the development of broadly neutralizing antibody responses.https://www.frontiersin.org/article/10.3389/fmicb.2019.01096/fullHIV-1envelope genebroadly neutralizing antibodiesglycosylationdiversity
spellingShingle Dai Zhang
Dai Zhang
Sen Zou
Yuanyuan Hu
Jiali Hou
Xintao Hu
Li Ren
Liying Ma
Xiang He
Yiming Shao
Kunxue Hong
Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
Frontiers in Microbiology
HIV-1
envelope gene
broadly neutralizing antibodies
glycosylation
diversity
title Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
title_full Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
title_fullStr Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
title_full_unstemmed Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
title_short Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
title_sort characteristics of envelope genes in a chinese chronically hiv 1 infected patient with broadly neutralizing activity
topic HIV-1
envelope gene
broadly neutralizing antibodies
glycosylation
diversity
url https://www.frontiersin.org/article/10.3389/fmicb.2019.01096/full
work_keys_str_mv AT daizhang characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT daizhang characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT senzou characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT yuanyuanhu characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT jialihou characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT xintaohu characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT liren characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT liyingma characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT xianghe characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT yimingshao characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity
AT kunxuehong characteristicsofenvelopegenesinachinesechronicallyhiv1infectedpatientwithbroadlyneutralizingactivity